Kymera Therapeutics (KYMR) Asset Utilization Ratio (2020 - 2026)

Kymera Therapeutics (KYMR) has reported Asset Utilization Ratio for 7 consecutive years, with 0.03 the latest figure, recorded in Q1 2026.

• In Q1 2026, Asset Utilization Ratio fell 51.41% year-over-year to 0.03; the TTM figure through Mar 2026 stood at 0.03 (down 51.41% YoY), while the FY2025 annual figure was 0.03, down 52.43% from the prior year.
• Asset Utilization Ratio rose to 0.03 in Q1 2026 per KYMR's latest filing, from 0.03 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.14 in Q4 2023 and bottomed at 0.03 in Q4 2025.
• Historically, Asset Utilization Ratio has averaged 0.08 across 5 years, with a median of 0.08 in 2022.
• Annual changes were most pronounced in 2023 — Asset Utilization Ratio soared 84.72% — and 2024, when it sank 66.43%.
• Kymera Therapeutics' Asset Utilization Ratio stood at 0.08 in 2022, then jumped by 84.72% to 0.14 in 2023, then tumbled by 66.43% to 0.05 in 2024, then tumbled by 41.06% to 0.03 in 2025, then rose by 9.46% to 0.03 in 2026.
• Business Quant data shows KYMR's Asset Utilization Ratio at 0.03 in Q1 2026, 0.03 in Q4 2025, and 0.04 in Q3 2025.